Immunological Age Modeling From Immune Cell Population Dynamics
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for tracking immune-system aging over time are limited by short durations, low resolution, and inability to capture the system's complexity, leading to incomplete understanding of immunological aging and variability among individuals.
Innovation Solution
A method involving the measurement of relative abundance of specific immune cell populations and gene expression, combined with dynamical systems analysis, to determine immunological age and predict risk of illness and mortality.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If longitudinal studies track the immune-system over extended periods with high resolution, then comprehensive system-wide understanding of immunological aging is achieved, but study duration and resource requirements increase significantly
Solution Approach 1:
The patent creates a computational model that replicates the complex dynamics of the immune system by measuring a limited set of key immune cell populations and using mathematical algorithms to simulate and predict the behavior of the entire immune system. This copying approach allows comprehensive understanding without requiring exhaustive measurement of all immune components over extended periods
Solution Approach 2:
The patent transforms the study approach by changing from measuring numerous immune parameters at multiple time points to measuring a specific subset of immune cell populations (CD4+ T cells, CD8+ T cells, B cells, NK cells, monocytes) and using dynamical systems analysis to derive comprehensive insights. This parameter transformation enables reliable longitudinal tracking with reduced resource requirements
2Reliability
If data from independent studies addressing different immune-components are merged, then comprehensive system-wide understanding is achieved, but data integration complexity and loss of information increase
Solution Approach 1:
The patent merges data from multiple independent studies by developing a unified computational framework that integrates measurements of different immune cell populations using dynamical systems theory. The model combines information from CD4+ T cells, CD8+ T cells, B cells, NK cells, and monocytes into a cohesive representation of immune system aging, preserving the unique contributions of each component while achieving system-wide understanding
Solution Approach 2:
The patent introduces computational models and algorithms as intermediaries that translate and harmonize data from different immune component studies. These mathematical tools serve as mediators that reconcile variations in measurement methods and protocols across independent studies, enabling accurate data integration without direct merging of raw data
3Ease of operation
If low-dimensional biomarkers are used to capture immune aging, then simplicity and ease of use increase, but ability to capture system complexity decreases
Solution Approach 1:
The patent extracts essential information from the complex immune system by identifying and measuring a specific subset of key immune cell populations that serve as representative biomarkers. By focusing on CD4+ T cells, CD8+ T cells, B cells, NK cells, and monocytes, the method captures the essential dynamics of immune aging while maintaining simplicity of measurement and interpretation
Solution Approach 2:
The patent adds a computational dimension to low-dimensional biomarker measurement by applying dynamical systems analysis and machine learning algorithms to the measured immune cell populations. This transformation converts simple cell count measurements into comprehensive predictions of immune system aging and health outcomes, effectively adding informational dimensions without increasing measurement complexity
Data Source
AI summary
Methods of determining an immunological age of a subject comprising measuring relative abundance of at least 3 immune cell populations in a blood sample from the subject and determining an immunological age of the subject based on the measured relative abundances are provided. Methods of diagnosing increased risk of illness and mortality are also provided, as are kits for performing these methods.